People least likely to quit using GLP-1 drugs are those using them to manage diabetes and those with higher incomes
The mechanisms potentially contributing to cardiovascular protection may include effects on weight, glycemic control, blood pressure, and possibly direct effects on vascular inflammation and lipid metabolism, though these mechanisms remain under investigation
While formal guidelines from organizations like ACSM and NSCA often specify intensity ranges based on percentages of one-rep max (e.g., 70-85% 1RM for hypertrophy/strength) 39 , these precise targets can be impractical and intimidating for beginners, especially those navigating potential GLP-1 side effects like fatigue or nausea
Late-diabetic complications, inflammatory bowel disease (IBD), kidney disease, and previous falls (binary variables) were identified through diagnosis codes